Tech Company Financing Transactions
Lineagen Funding Round
On 1/26/2015, Lineagen received $12.2 million in Series C funding from private investors.
Transaction Overview
Company Name
Announced On
1/26/2015
Transaction Type
Venture Equity
Amount
$12,173,420
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2677 E Parleys Way
Salt Lake City, UT 84109
USA
Salt Lake City, UT 84109
USA
Phone
Website
Email Address
Overview
The company is developing a diagnostic platform that targets autism, multiple sclerosis, cancer and chronic obstructive pulmonary disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Paul
Vice President
Rena Vanzo
VP - Human Resources
Leanne Hill
VP - Operations
Mathew Harrison
VP - Sales
Jeffrey Knupp
Browse more venture capital transactions:
Prev: 1/26/2015: Accelergy venture capital transaction
Next: 1/26/2015: Iora Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs